Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 141 (RN7SKP141) is a human pseudogene related to the *RN7SK* small nuclear RNA gene. Pseudogenes are dysfunctional segments of DNA that resemble functional genes but typically do not produce functional products. Unlike the authentic *RN7SK* small nuclear RNA, which plays an essential role in regulating RNA polymerase II transcription elongation via sequestration of P-TEFb and other critical cellular processes[1][2][3][5], RN7SKP141 has no documented biological function, clinical relevance, associated disease implications, or drug interactions. It is not considered a therapeutic target. The inclusion of RN7SKP141 in target lists is likely due to misannotation or mistaken identity with the functional *RN7SK* gene. The *RN7SK* gene encodes a noncoding small nuclear RNA, essential in transcriptional regulation and implicated in diverse cellular functions and certain disease states[1][2][3][5]. However, *pseudogenes* such as RN7SKP141 are typically **inactive DNA fragments**; they are not receptors, enzymes, or other molecular targets for pharmacological intervention and should not be treated as such.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 141 (RN7SKP141).